Affinity Chromatography - Department of Molecular and Cellular ...

More documents

Recommendations

Info

BioProcess Media for large-scale production Specific BioProcess Media have been designed for each chromatographic stage in a process from Capture to Polishing. Large capacity production integrated with clear ordering and delivery routines ensure that BioProcess Media are available in the right quantity, at the right place, at the right time. Amersham Pharmacia Biotech can assure future supplies of BioProcess Media, making them a safe investment for long-term production. The media are produced following validated methods and tested under strict control to fulfil high performance specifications. A certificate of analysis is available with each order. Regulatory Support Files contain details of performance, stability, extractable compounds and analytical methods. The essential information in these files gives an invaluable starting point for process validation, as well as providing support for submissions to regulatory authorities. Using BioProcess Media for every stage results in an easily validated process. High flow rate, high capacity and high recovery contribute to the overall economy of an industrial process. All BioProcess Media have chemical stability to allow efficient cleaning and sanitization procedures. Packing methods are established for a wide range of scales and compatible large-scale columns and equipment are available. Please refer to the latest BioProcess Products Catalogue from Amersham Pharmacia Biotech for further details of our products and services for large-scale production. Custom Designed Media and Columns Prepacked columns, made according to the client's choice from the Amersham Pharmacia Biotech range of columns and media, can be supplied by the Custom Products Group. Custom Designed Media (CDM) can be produced for specific industrial process separations when suitable media are not available from the standard range. The CDM group at Amersham Pharmacia Biotech works in close collaboration with the user to design, manufacture, test and deliver media for specialized separation requirements. When a chromatographic step is developed to be an integral part of a manufacturing process, the choice of column is important to ensure consistent performance and reliable operation. Amersham Pharmacia Biotech provides a wide range of columns that ensures the highest performance from all our purification media and meets the demands of modern pharmaceutical manufacturing. Please ask your local representative for further details of CDM products and services. 12
Common terms in affinity chromatography Matrix: for ligand attachment. Matrix should be chemically and physically inert. Spacer arm: used to improve binding between ligand and target molecule by overcoming any effects of steric hindrance. Ligand: molecule that binds reversibly to a specific target molecule or group of target molecules. Binding: buffer conditions are optimized to ensure that the target molecules interact effectively with the ligand and are retained by the affinity medium as all other molecules wash through the column. Elution: buffer conditions are changed to reverse (weaken) the interaction between the target molecules and the ligand so that the target molecules can be eluted from the column. Wash: buffer conditions that wash unbound substances from the column without eluting the target molecules or that re-equilibrate the column back to the starting conditions (in most cases the binding buffer is used as a wash buffer). Ligand coupling: covalent attachment of a ligand to a suitable pre-activated matrix to create an affinity medium. Pre-activated matrices: matrices which have been chemically modified to facilitate the coupling of specific types of ligand. 13
Page 1 and 2: Affinity Chromatography Principles
Page 3 and 4: Affinity Chromatography Principles
Page 5 and 6: Serine proteases and zymogens with
Page 7: Appendix 4 ........................
Page 10 and 11: This handbook describes the role of
Page 12 and 13: Affinity chromatography is also use
Page 17 and 18: Chapter 2 Affinity chromatography i
Page 19 and 20: Avoid using magnetic stirrers as th
Page 21 and 22: pH elution A change in pH alters th
Page 23 and 24: 0.6 0.4 0.2 0 A280 pH selected for
Page 25 and 26: Situation Cause Remedy Protein does
Page 27 and 28: Chapter 3 Purification of specific
Page 29 and 30: Table 2. Relative binding strengths
Page 31 and 32: Purification examples Figure 11 sho
Page 33 and 34: MAbTrap Kit Fig. 13. MAbTrap Kit, r
Page 35 and 36: Media characteristics Ligand Compos
Page 37 and 38: A 280 nm 2.0 1.5 1.0 0.5 Column: rP
Page 39 and 40: Desalt and/or transfer purified IgG
Page 41 and 42: Performing a separation Column: Rec
Page 43 and 44: M r 97 000 66 000 45 000 30 000 20
Page 45 and 46: in The Recombinant Protein Handbook
Page 47 and 48: Cleaning These procedures are appli
Page 49 and 50: Purification examples Figures 24 an
Page 51 and 52: Nickel solution: 0.1 M NiSO 4 Bindi
Page 53 and 54: Protein A fusion proteins IgG Sepha
Page 55 and 56: Purification or removal of serine p
Page 57 and 58: Sample: 2 ml clarified E. coli homo
Page 59 and 60: Serine proteases and zymogens with
Page 61 and 62: DNA binding proteins HiTrap Heparin
Page 63 and 64: Sample: Column: Binding buffer: Elu
Page 65 and 66:
Media characteristics Ligand densit
Page 67 and 68:
Sample: Pooled and frozen human pla
Page 69 and 70:
The harsh conditions required to br
Page 71 and 72:
Purification or removal of albumin
Page 73 and 74:
IFN-act. A units 280 nm 250 0.12 20
Page 75 and 76:
Purification options Binding capaci
Page 77 and 78:
Sepharose NH (CH 2) n NH N N O N N
Page 79 and 80:
If detergent or denaturing agents h
Page 81 and 82:
Glycoproteins or polysaccharides Co
Page 83 and 84:
For complex samples containing glyc
Page 85 and 86:
For complex samples containing glyc
Page 87 and 88:
Chemical stability Avoid exposure t
Page 89 and 90:
Proteins and peptides with exposed
Page 91 and 92:
Several methods can be used to dete
Page 93 and 94:
Media characteristics Composition M
Page 95 and 96:
Performing a separation Binding buf
Page 97 and 98:
Do not store the suspension for lon
Page 99 and 100:
Sepharose has been modified and dev
Page 101 and 102:
Ligand coupling Several methods are
Page 103 and 104:
Couple a ligand through the least c
Page 105 and 106:
Table 9 summarizes recommended liga
Page 107 and 108:
Coupling through the primary amine
Page 109 and 110:
Ligand and column preparation 1. Di
Page 111 and 112:
Options Product Spacer Coupling con
Page 113 and 114:
100 80 Coupled substance, % 60 40 2
Page 115 and 116:
Coupling small ligands through amin
Page 117 and 118:
Ligand coupling 1. Add the ligand s
Page 119 and 120:
Alternative coupling solutions: Dis
Page 121 and 122:
Media characteristics Product Compo
Page 123 and 124:
Ligands containing amino groups can
Page 125 and 126:
Chapter 6 Affinity chromatography a
Page 127 and 128:
Resolution is achieved by the selec
Page 129 and 130:
For any capture step, select the te
Page 131 and 132:
Appendix 1 Sample preparation Sampl
Page 133 and 134:
Remove salts from proteins with mol
Page 135 and 136:
1. Filter (0.45 µm) or centrifuge
Page 137 and 138:
For laboratory scale operations, Ta
Page 139 and 140:
Removal of lipoproteins Lipoprotein
Page 141 and 142:
Appendix 2 Selection of purificatio
Page 143 and 144:
4. Estimate the amount of slurry (r
Page 145 and 146:
Appendix 5 Conversion data: protein
Page 147 and 148:
Middle unit residue (-H 2 0) Charge
Page 149 and 150:
Expected results when changing cond
Page 151 and 152:
Expected results with competitive e
Page 153 and 154:
Appendix 8 Analytical assays during
Page 155 and 156:
Appendix 9 Storage of biological sa
Page 157 and 158:
Ordering information Product Quanti
Page 159 and 160:
STREAMLINE, Sepharose, HiTrap, ÄKT
show all

Affinity Chromatography - Department of Molecular and Cellular ...

Create successful ePaper yourself

Delete template?

Save as template?